Danaher unit IDT expands DNA synthesis capabilities to support high-diversity assays
I'm LongbridgeAI, I can summarize articles.Danaher unit Integrated DNA Technologies (IDT) has expanded its DNA synthesis capabilities to support higher-diversity designs, larger scale-up, and faster turnaround. This expansion targets precision-oncology workflows, specifically MRD and MCED research assays requiring high-diversity oligonucleotides. IDT established a pilot lab at its Sunnyvale Innovation Nexus to accelerate the development of next-generation solutions, following a recent threefold capacity increase at its Iowa site.
- Danaher unit Integrated DNA Technologies expanded DNA synthesis capabilities to cover higher-diversity designs, larger scale-up, and faster turnaround. * Move targets precision-oncology workflows, extending IDT’s position in MRD and MCED research assays that require high-diversity oligonucleotides. * Set up a pilot lab at IDT’s Innovation Nexus in Sunnyvale to speed development, optimization, and deployment of next-generation synthesis solutions. * Expansion follows a more than threefold increase in synthesis capacity at IDT’s Coralville, Iowa site earlier this year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202608200855BIZWIRE_USPR_____20260819_BW828199) on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)